Profile cover photo
Profile photo
VBI Vaccines Inc.
13 followers -
VBI Vaccines Inc. (Nasdaq: VBIV) is a commercial-stage biopharmaceutical company developing a next generation of vaccines to address unmet needs in infectious disease and immuno-oncology.
VBI Vaccines Inc. (Nasdaq: VBIV) is a commercial-stage biopharmaceutical company developing a next generation of vaccines to address unmet needs in infectious disease and immuno-oncology.

13 followers
About
VBI Vaccines Inc.'s posts

Post has attachment

Post has attachment
One in ten pregnant women with #Zika in the U.S. have babies with birth defects says new @CDCgov research: https://www.nytimes.com/2017/04/04/health/zika-birth-defects-united-states.html

Post has attachment
The Rationale of Developing a More Immunogenic Hepatitis B Vaccine for Healthcare Workers: http://www.vbivaccines.com/wire/healthcare-workers-hbv-infection/

Post has attachment
Download VBI’s World Vaccine Congress presentations for updates on Sci-B-Vac™ and our GBM Immunotherapy Program: https://www.vbivaccines.com/wire/wvc-2017

Post has attachment

Post has attachment
VBI to Present Updates on Multiple Programs at the World Vaccine Congress: https://www.vbivaccines.com/wire/wvc-2017/ #WVCUSA

Post has attachment

Post has attachment
Research suggests that improved hepatitis B vaccine options for persons with #ESRD may be beneficial: https://www.vbivaccines.com/wire/esrd-hbv-infection/

Post has attachment

Post has attachment
Wait while more posts are being loaded